{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:00:27Z","timestamp":1790776827932,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000155","name":"Government of Canada Social Sciences and Humanities Research Council","doi-asserted-by":"publisher","award":["430-2018-00756"],"award-info":[{"award-number":["430-2018-00756"]}],"id":[{"id":"10.13039\/501100000155","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Child Abuse & Neglect"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.chiabu.2026.108287","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T22:11:59Z","timestamp":1787955119000},"page":"108287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Psychotropic medication use in school-aged children in foster care and residential care within child protective services"],"prefix":"10.1016","volume":"181","author":[{"given":"Elo\u00efse","family":"Parizeau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Lafortune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4422-1780","authenticated-orcid":false,"given":"Sebastien","family":"Monette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.chiabu.2026.108287_bb0005","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1542\/peds.2009-0048","article-title":"Improving mental health services in primary care: Reducing administrative and financial barriers to access and collaboration","volume":"123","author":"American Academy of Child and Adolescent Psychiatry Committee on Health Care Access & Economics Task Force on Mental Health","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.chiabu.2026.108287_bb0010","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013"},{"issue":"1","key":"10.1016\/j.chiabu.2026.108287_bb0015","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1037\/a0029891","article-title":"Guidelines for psychological evaluations in child protection matters","volume":"68","author":"American Psychological Association","year":"2013","journal-title":"The American Psychologist"},{"key":"10.1016\/j.chiabu.2026.108287_bb0020","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12889-022-14677-6","article-title":"Geographic variation and sociodemographic correlates of prescription psychotropic drug use among children and youth in Ontario, Canada: A population-based study","volume":"23","author":"Antoniou","year":"2023","journal-title":"BMC Public Health"},{"issue":"3","key":"10.1016\/j.chiabu.2026.108287_bb0025","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1089\/cap.2020.0162","article-title":"Polypharmacy in the management of attention-deficit\/hyperactivity disorder in children and adolescents: A review and update","volume":"31","author":"Baker","year":"2021","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"10.1016\/j.chiabu.2026.108287_bb0030","series-title":"Barkley Deficits in Executive Functioning Scale\u2014Children and Adolescents (BDEFS-CA)","author":"Barkley","year":"2012"},{"issue":"6","key":"10.1016\/j.chiabu.2026.108287_bb5000","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1176\/appi.ps.55.6.706","article-title":"Use of psychotropic medications by youths in therapeutic foster care and group homes","volume":"55","author":"Breland-Noble","year":"2004","journal-title":"Psychiatric Services"},{"key":"10.1016\/j.chiabu.2026.108287_bb0040","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s10826-013-9882-3","article-title":"Use of psychotropic medications among youth in treatment foster care","volume":"23","author":"Brenner","year":"2014","journal-title":"Journal of Child and Family Studies"},{"issue":"7","key":"10.1016\/j.chiabu.2026.108287_bb0045","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002622","article-title":"The prevalence of mental disorders among children and adolescents in the child welfare system","volume":"95","author":"Bronsard","year":"2016","journal-title":"Medicine"},{"issue":"10","key":"10.1016\/j.chiabu.2026.108287_bb0050","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1016\/j.childyouth.2011.05.014","article-title":"Prevalence rate of DSM mental disorders among adolescents living in residential group homes of the French Child Welfare System","volume":"33","author":"Bronsard","year":"2011","journal-title":"Children and Youth Services Review"},{"key":"10.1016\/j.chiabu.2026.108287_bb0055","series-title":"Canadian ADHD practice guidelines","author":"CADDRA - Canadian ADHD Resource Alliance","year":"2020"},{"key":"10.1016\/j.chiabu.2026.108287_bb0060","series-title":"Conners Comprehensive Behavior Rating Scales","author":"Conners","year":"2008"},{"key":"10.1016\/j.chiabu.2026.108287_bb0065","series-title":"Conners Comprehensive Behavior Rating Scales: DSM-5 updates","author":"Conners","year":"2014"},{"issue":"2","key":"10.1016\/j.chiabu.2026.108287_bb0070","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1089\/cap.2005.15.302","article-title":"A naturalistic study of medication reduction in a residential treatment setting","volume":"15","author":"Connor","year":"2005","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"1","key":"10.1016\/j.chiabu.2026.108287_bb0075","first-page":"40","article-title":"An overview of the treatment of eating disorders in adults and adolescents: Pharmacology and psychotherapy","volume":"32","author":"Costandache","year":"2023","journal-title":"Advances in Psychiatry and Neurology"},{"issue":"6","key":"10.1016\/j.chiabu.2026.108287_bb0080","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-2444","article-title":"Racial and ethnic differences in ADHD treatment quality among Medicaid-enrolled youth","volume":"139","author":"Cummings","year":"2017","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.chiabu.2026.108287_bb0085","doi-asserted-by":"crossref","DOI":"10.7870\/cjcmh-2017-020","article-title":"Pr\u00e9valence des prescriptions psychopharmacologiques aux enfants plac\u00e9s en foyer de groupe et en centre de r\u00e9adaptation","volume":"36","author":"Desjardins","year":"2017","journal-title":"Canadian Journal of Community Mental Health"},{"issue":"1","key":"10.1016\/j.chiabu.2026.108287_bb0090","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/1756285610390261","article-title":"Treatment strategies for tics in Tourette syndrome","volume":"4","author":"Eddy","year":"2011","journal-title":"Therapeutic Advances in Neurological Disorders"},{"issue":"5","key":"10.1016\/j.chiabu.2026.108287_bb0095","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00127-009-0100-y","article-title":"The mental health of young children with intellectual disabilities or borderline intellectual functioning","volume":"45","author":"Emerson","year":"2010","journal-title":"Social Psychiatry and Psychiatric Epidemiology"},{"key":"10.1016\/j.chiabu.2026.108287_bb5010","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1176\/ps.2009.60.12.1595","article-title":"Identifying questionable psychotropic prescribing practices for Medicaid recipients in New York State","volume":"60","author":"Essock","year":"2009","journal-title":"Psychiatric Services"},{"key":"10.1016\/j.chiabu.2026.108287_bb0100","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.neubiorev.2021.01.022","article-title":"The world federation of ADHD international consensus statement: 208 evidence-based conclusions about the disorder","volume":"128","author":"Faraone","year":"2021","journal-title":"Neuroscience & Biobehavioral Reviews"},{"issue":"4","key":"10.1016\/j.chiabu.2026.108287_bb0105","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1089\/cap.2006.16.474","article-title":"Psychotropic drug use with European American and American Indian children in foster care","volume":"16","author":"Ferguson","year":"2006","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"11","key":"10.1016\/j.chiabu.2026.108287_bb0110","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1176\/appi.ps.201300410","article-title":"Trends in psychotropic polypharmacy among youths enrolled in Ohio Medicaid, 2002\u20132008","volume":"65","author":"Fontanella","year":"2014","journal-title":"Psychiatric Services"},{"key":"10.1016\/j.chiabu.2026.108287_bb0115","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1469-8749.2000.tb00346.x","article-title":"An international perspective on Tourette syndrome: selected findings from 3500 individuals in 22 countries","volume":"42","author":"Freeman","year":"2000","journal-title":"Developmental Medicine & Child Neurology"},{"issue":"7","key":"10.1016\/j.chiabu.2026.108287_bb0125","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1007\/s00213-021-05809-8","article-title":"Psychotropic use in children and adolescents in Scandinavia and Catalonia: a 10-year population-based study","volume":"238","author":"G\u00f3mez-Lumbreras","year":"2021","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.1016\/j.chiabu.2026.108287_bb5025","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1089\/cap.2008.012","article-title":"Psychotropic medication utilization at a group-home residential facility for children and adolescents","volume":"18","author":"Handwerk","year":"2008","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"10.1016\/j.chiabu.2026.108287_bb0130","series-title":"Surveillance du trouble du d\u00e9ficit de l'attention avec ou sans hyperactivit\u00e9 (TDAH) chez les enfants et jeunes adultes au Qu\u00e9bec: usage des m\u00e9dicaments","author":"Institut national de sant\u00e9 publique du Qu\u00e9bec (INSPQ)","year":"2022"},{"issue":"2","key":"10.1016\/j.chiabu.2026.108287_bb0135","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-3751","article-title":"Children exposed to maltreatment: Assessment and the role of psychotropic medication","volume":"145","author":"Keeshin","year":"2020","journal-title":"Pediatrics"},{"issue":"11","key":"10.1016\/j.chiabu.2026.108287_bb0140","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1177\/00048674211067720","article-title":"Trends in prescription of psychotropic medications to children and adolescents in Australian primary care from 2011 to 2018","volume":"56","author":"Klau","year":"2022","journal-title":"Australian & New Zealand Journal of Psychiatry"},{"issue":"1","key":"10.1016\/j.chiabu.2026.108287_bb0145","first-page":"157","article-title":"Pr\u00e9valence et facteurs associ\u00e9s \u00e0 la prescription de m\u00e9dicaments psychotropes chez les sujets plac\u00e9s en centre jeunesse","volume":"33","author":"Lafortune","year":"2004","journal-title":"Revue de Psycho\u00e9ducation"},{"issue":"6","key":"10.1016\/j.chiabu.2026.108287_bb0150","first-page":"502","article-title":"Practice parameter for the assessment and management of youth involved with the child welfare system","volume":"54","author":"Lee","year":"2015","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"1","key":"10.1016\/j.chiabu.2026.108287_bb5015","doi-asserted-by":"crossref","DOI":"10.1186\/1753-2000-7-39","article-title":"Mental disorders in foster children : A study of prevalence, comorbidity and risk factors","volume":"7","author":"Lehmann","year":"2013","journal-title":"Child and Adolescent Psychiatry and Mental Health"},{"issue":"4","key":"10.1016\/j.chiabu.2026.108287_bb0155","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s40688-014-0029-3","article-title":"Assessing psychosocial impairment in children and adolescents: A review of the Barkley Functional Impairment Scale (BFIS)","volume":"18","author":"McGill","year":"2014","journal-title":"Contemporary School Psychology"},{"issue":"6","key":"10.1016\/j.chiabu.2026.108287_bb0160","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/14656566.2018.1445720","article-title":"Psychotropic medications for highly vulnerable children","volume":"19","author":"McLaren","year":"2018","journal-title":"Expert Opinion on Pharmacotherapy"},{"issue":"9","key":"10.1016\/j.chiabu.2026.108287_bb5020","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1176\/appi.ps.201900465","article-title":"Psychotropic use among youths with intellectual and developmental disabilities","volume":"72","author":"McLaren","year":"2021","journal-title":"Psychiatric Services"},{"issue":"3","key":"10.1016\/j.chiabu.2026.108287_bb0165","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s40653-023-00547-9","article-title":"Mental health disorders and psychotropic medication: prevalence and related characteristics among individuals in foster care","volume":"16","author":"McLeigh","year":"2023","journal-title":"Journal of Child & Adolescent Trauma"},{"key":"10.1016\/j.chiabu.2026.108287_bb0170","series-title":"Rapport du comit\u00e9 de travail sur la sant\u00e9 mentale des jeunes suivis par les centres jeunesse [Report of the working committee on the mental health of youth followed by youth centers]","author":"Minist\u00e8re de la Sant\u00e9 et des Services sociaux (MSSS)","year":"2007"},{"key":"10.1016\/j.chiabu.2026.108287_bb0175","author":"Monette"},{"key":"10.1016\/j.chiabu.2026.108287_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.chiabu.2025.107587","article-title":"The extended modified maltreatment classification system (EMMCS): A validation study","author":"Monette","year":"2025","journal-title":"Child Abuse and Neglect"},{"key":"10.1016\/j.chiabu.2026.108287_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.chiabu.2024.107155","article-title":"Mental disorder diagnoses and symptoms and functional impairment in school-age children in the care of child protective services","volume":"159","author":"Monette","year":"2025","journal-title":"Child Abuse & Neglect"},{"issue":"3","key":"10.1016\/j.chiabu.2026.108287_bb0190","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.jadohealth.2023.04.022","article-title":"A longitudinal analysis of concerning psychotropic medication regimens among adolescents in foster care","volume":"73","author":"Palmer","year":"2023","journal-title":"Journal of Adolescent Health"},{"issue":"12","key":"10.1016\/j.chiabu.2026.108287_bb0195","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","article-title":"A simulation study of the number of events per variable in logistic regression analysis","volume":"49","author":"Peduzzi","year":"1996","journal-title":"Journal of Clinical Epidemiology"},{"issue":"10","key":"10.1016\/j.chiabu.2026.108287_bb0200","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1089\/cap.2019.0018","article-title":"The pharmacoepidemiology of psychotropic medication use in Canadian children from 2012 to 2016","volume":"29","author":"Pringsheim","year":"2019","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"10","key":"10.1016\/j.chiabu.2026.108287_bb5005","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1001\/jamapediatrics.2023.3068","article-title":"Psychotropic medication and psychotropic polypharmacy among children and adolescents in the US child welfare system","volume":"177","author":"Radel","year":"2023","journal-title":"JAMA Pediatrics"},{"issue":"1","key":"10.1016\/j.chiabu.2026.108287_bb0205","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1089\/cap.2005.15.97","article-title":"Psychotropic medication use in a national probability sample of children in the child welfare system","volume":"15","author":"Raghavan","year":"2005","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"6","key":"10.1016\/j.chiabu.2026.108287_bb0210","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/bcp.12732","article-title":"A systematic review of the emerging definition of \u2018deprescribing\u2019 with network analysis: implications for future research and clinical practice","volume":"80","author":"Reeve","year":"2015","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"2","key":"10.1016\/j.chiabu.2026.108287_bb0215","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/019874290803300204","article-title":"Prevalence rates of psychotropic medications for students placed in residential facilities","volume":"33","author":"Ryan","year":"2008","journal-title":"Behavioral Disorders"},{"issue":"5","key":"10.1016\/j.chiabu.2026.108287_bb0220","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jamainternmed.2015.0324","article-title":"Reducing inappropriate polypharmacy: The process of deprescribing","volume":"175","author":"Scott","year":"2015","journal-title":"JAMA Internal Medicine"},{"issue":"3","key":"10.1016\/j.chiabu.2026.108287_bb0225","first-page":"3","article-title":"Prescription medication use among Canadian children and youth, 2012 to 2017","volume":"32","author":"Servais","year":"2021","journal-title":"Health Reports"},{"key":"10.1016\/j.chiabu.2026.108287_bb0230","series-title":"Monographie de produit incluant les renseignements pour le patient sur le m\u00e9dicament Intuniv XR\u00ae","author":"Takeda Canada Inc.","year":"2020"},{"issue":"5","key":"10.1016\/j.chiabu.2026.108287_bb0235","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-1118","article-title":"Mental and physical health of children in foster care","volume":"138","author":"Turney","year":"2016","journal-title":"Pediatrics"},{"issue":"12","key":"10.1016\/j.chiabu.2026.108287_bb0240","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1136\/adc.2004.050468","article-title":"Increased prescribing trends of paediatric psychotropic medications","volume":"89","author":"Wong","year":"2004","journal-title":"Archives of Disease in Childhood"},{"key":"10.1016\/j.chiabu.2026.108287_bb0245","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00228-012-1343-1","article-title":"Prescription drug dispensing profiles for one million children: a population-based analysis","volume":"69","author":"Zhang","year":"2013","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"3","key":"10.1016\/j.chiabu.2026.108287_bb0250","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1089\/cap.1999.9.135","article-title":"Psychotropic medication treatment patterns among school-aged children in foster care","volume":"9","author":"Zima","year":"1999","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"1","key":"10.1016\/j.chiabu.2026.108287_bb0255","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1001\/archpedi.157.1.17","article-title":"Psychotropic practice patterns for youth: A 10-year perspective","volume":"157","author":"Zito","year":"2003","journal-title":"Archives of Pediatrics & Adolescent Medicine"},{"issue":"1","key":"10.1016\/j.chiabu.2026.108287_bb0260","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1542\/peds.2007-0212","article-title":"Psychotropic medication patterns among youth in foster care","volume":"121","author":"Zito","year":"2008","journal-title":"Pediatrics"}],"container-title":["Child Abuse & Neglect"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145213426004072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145213426004072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:30:10Z","timestamp":1790775010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145213426004072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":56,"alternative-id":["S0145213426004072"],"URL":"https:\/\/doi.org\/10.1016\/j.chiabu.2026.108287","relation":{},"ISSN":["0145-2134"],"issn-type":[{"value":"0145-2134","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psychotropic medication use in school-aged children in foster care and residential care within child protective services","name":"articletitle","label":"Article Title"},{"value":"Child Abuse & Neglect","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chiabu.2026.108287","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108287"}}